Terug
40
Dagbereik
€ 264,35
€ 270,59
52-Weeksbereik
€ 209,38
€ 293,72
Volume
439.069
50D / 200D Gem.
€ 272,78
/
€ 267,35
Vorige Slotkoers
€ 263,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 25,0 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | 10,5 | 3,7 |
| Net Margin % | 6,3 | 3,8 |
| Rev Growth 5Y % | 1,5 | 10,0 |
| D/E | 0,8 | 0,2 |
Belangrijkste Punten
Revenue grew 1,52% annually over 5 years — modest growth
Earnings grew 17,49% over the past year
ROE of 10,51% — decent returns on equity
Generating 1,21B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,73%
Cash machine — converts 137,59% of earnings into free cash flow
Groei
Revenue Growth (5Y)
1,52%
Revenue (1Y)7,25%
Earnings (1Y)17,49%
FCF Growth (3Y)17,46%
Kwaliteit
Return on Equity
10,51%
ROIC7,19%
Net Margin6,28%
Op. Margin10,87%
Veiligheid
Debt / Equity
0,84
Current Ratio1,42
Interest Coverage6,77
Waardering
P/E Ratio
25,01
P/B Ratio2,54
EV/EBITDA18,86
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,25% | Revenue Growth (3Y) | 7,11% |
| Earnings Growth (1Y) | 17,49% | Earnings Growth (3Y) | 44,81% |
| Revenue Growth (5Y) | 1,52% | Earnings Growth (5Y) | -22,08% |
| Profitability | |||
| Revenue (TTM) | 13,95B | Net Income (TTM) | 876,50M |
| ROE | 10,51% | ROA | 4,77% |
| Gross Margin | 26,75% | Operating Margin | 10,87% |
| Net Margin | 6,28% | Free Cash Flow (TTM) | 1,21B |
| ROIC | 7,19% | FCF Growth (3Y) | 17,46% |
| Safety | |||
| Debt / Equity | 0,84 | Current Ratio | 1,42 |
| Interest Coverage | 6,77 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 25,01 | P/B Ratio | 2,54 |
| P/S Ratio | 1,57 | PEG Ratio | 1,28 |
| EV/EBITDA | 18,86 | Dividend Yield | 0,01% |
| Market Cap | 21,92B | Enterprise Value | 28,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13,95B | 13,01B | 12,16B | 11,86B | 13,14B |
| Net Income | 876,50M | 746,00M | 418,00M | 1,28B | 2,38B |
| EPS (Diluted) | 10,46 | 8,84 | 4,77 | 13,96 | 24,38 |
| Gross Profit | 3,73B | 3,62B | 3,36B | 3,71B | 4,99B |
| Operating Income | 1,52B | 1,09B | 725,60M | 1,44B | 3,05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18,39B | 18,38B | 16,73B | 20,16B | 20,39B |
| Total Liabilities | 9,76B | 10,31B | 8,83B | 10,04B | 10,09B |
| Shareholders' Equity | 8,62B | 8,05B | 7,88B | 10,10B | 10,27B |
| Total Debt | 7,20B | 7,27B | 5,95B | 6,25B | 6,34B |
| Cash & Equivalents | 532,30M | 1,52B | 536,80M | 320,60M | 1,47B |
| Current Assets | 4,02B | 4,81B | 3,77B | 4,63B | 5,33B |
| Current Liabilities | 2,82B | 3,33B | 3,23B | 3,08B | 2,78B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#613 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026